Mette Reilev

Medicin og biovidenskab

1. Drug Utilization 100%
2. Severe Acute Respiratory Syndrome 85%
3. Coronavirus 83%
4. Denmark 72%
5. Odds Ratio 69%
6. Chronic Obstructive Pulmonary Disease 60%
7. Cohort Studies 47%
8. Nursing Homes 45%
9. Angiotensin Receptor Antagonists 44%
10. Prescriptions 42%
11. Human Influenza 40%
12. Adrenal Cortex Hormones 39%
13. Pharmaceutical Preparations 39%
14. Prescription Drugs 36%
15. Registries 36%
16. Mortality 35%
17. Microscopic Colitis 34%
18. Population 34%
19. Hospitalization 34%
20. SARS Virus 32%
21. Anti-Inflammatory Agents 32%
22. Omalizumab 31%
23. Intensive Care Units 31%
24. Lactulose 29%
25. Scandinavian and Nordic Countries 29%
26. Chronic Urticaria 29%
27. Budesonide 28%
28. Angiotensin-Converting Enzyme Inhibitors 28%
29. Bronchodilator Agents 28%
30. Proton Pump Inhibitors 27%
31. Morbidity 26%
32. Osteoporotic Fractures 26%
33. Histamine Antagonists 25%
34. Information Storage and Retrieval 23%
35. Polymerase Chain Reaction 22%
36. Renin-Angiotensin System 22%
37. Case-Control Studies 21%
38. Therapeutics 21%
39. Non-Steroidal Anti-Inflammatory Agents 20%
40. Calcium Channel Blockers 20%
41. Child 19%
42. Pneumonia 19%
43. Health 18%
44. Epidemiology 17%
45. Databases 16%
46. Amoxicillin 16%
47. Anti-Bacterial Agents 16%
48. Penicillin V 14%
49. Coronavirus Infections 14%
50. Hemorrhage 14%